Publications
- A. Blázquez,.
- J.J. Guillén,.
- C. Colomé,.
- O. Coll,.
- R. Vassena,.
- V. Vernaeve,.
- A. Rodríguez-Aranda,.
- J.J. Guillén,.
- M.J. López,.
- R. Vassena,.
- O. Coll,.
- V. Vernaeve,.
- D. Bodri,.
- J.J. Guillén,.
- D. Mataró,.
- A. Pujol,.
- O. Coll,.
- A. Galindo,.
- D. Bodri,.
- J.J. Guillén,.
- M. Colodrón,.
- V. Vernaeve,.
- O. Coll,.
- D. Bodri,.
- J.J. Guillén,.
- M. López,.
- V. Vernaeve,.
- O. Coll,.
- D. Bodri,.
- J.J. Guillén,.
- K. Schwenn,.
- S. Casadesus,.
- R. Vidal,.
- O. Coll,.
- D. Bodri,.
- J.J. Guillén,.
- M. Trullenque,.
- K. Schwenn,.
- C. Esteve,.
- O. Coll,.
- D. Bodri,.
- J.J. Guillén,.
- A. Polo,.
- M. Trullenque,.
- C. Esteve,.
- O. Coll,.
- D. Bodri,.
- V. Vernaeve,.
- F. Figueras,.
- R. Vidal,.
- J.J. Guillén,.
- O. Coll,.
- D. Bodri,.
- V. Vernaeve,.
- J.J. Guillén,.
- R. Vidal,.
- F. Figueras,.
- O. Coll,.
Empty follicle syndrome prevalence and management in oocyte donors
Hum Reprod. 2014 Oct 10;29(10):2221-7. doi: 10.1093/humrep/deu203. Epub 2014 Aug 1.
PMID: 25085799
Learning curves in 3-dimensional sonographic follicle monitoring during controlled ovarian stimulation
J Ultrasound Med. 2014 Apr;33(4):649-55. doi: 10.7863/ultra.33.4.649.
PMID: 24658944
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
Fertil Steril. 2009 Feb;91(2):365-71. doi: 10.1016/j.fertnstert.2007.11.049. Epub 2008 Mar 25.
PMID: 18367175
Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial.
Gynecol Endocrinol. 2009 Jan;25(1):60-6. doi: 10.1080/09513590802404013.
PMID: 19165664
Racial disparity in oocyte donation outcome: a multiethnic, matched cohort study.
Hum Reprod. 2010 Feb;25(2):436-42. Epub 2009 Nov 24
PMID: 19939832
Poor outcome in oocyte donation after elective transfer of a single cleavage-stage embryo in Turner syndrome patients.
Fertil Steril. 2009 Apr;91(4 Suppl):1489-92. doi: 10.1016/j.fertnstert.2008.07.1762. Epub 2008 Sep 14
PMID: 18793776
Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study.
Fertil Steril. 2010 May 1;93(7):2418-20. doi: 10.1016/j.fertnstert.2009.08.036. Epub 2009 Oct 2.
PMID: 19800620
Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles.
Reprod Biomed Online. 2008 Aug;17(2):237-43
PMID: 18681998
Oocyte donation in patients with Turner’s syndrome: a successful technique but with an accompanying high risk of hypertensive disorders during pregnancy.
Hum Reprod. 2006 Mar;21(3):829-32. Epub 2005 Nov 25.
PMID: 16311294
Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial.
Hum Reprod. 2006 Sep;21(9):2246-51. Epub 2006 May 16
PMID: 16704995